2.1 Multi-sector and One Health collaboration/coordination

2.3 Country progress with development of a national action plan on AMR

2.6 Is your country’s national planning on AMR integrated with other existing action plans or, strategies?

2.8.1 Country has laws or regulations on prescription and sale of antimicrobials, for human use.

2.8.2 Country has laws or regulations on prescription and sale of antimicrobials for terrestrial animal use.

2.8.3 Country has laws or regulations on prescription and sale of antimicrobials for aquatic animals.

2.8.5 Country has laws or regulations that prohibits the use of antibiotics for growth promotion in terrestrial animals in the absence of risk analysis.

2.8.6 Country has legislation on the registration and use of applicable pesticides with antimicrobial effects, such as bactericides and fungicides used in plant production.

2.10 Youth education and AMR

2.11 Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies?

2.12 Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies

2.13 Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance

2.9 Raising awareness and understanding of AMR risks and response

2.4.b Does the multisector coordination mechanism review current and previous year data from TrACSS as a way to monitor progress of AMR national action plan implementation?

3.1 Training and professional education on AMR in the human health sector

3.2 National monitoring system for consumption and rational use of antimicrobials in human health

3.3 National surveillance system for antimicrobial resistance (AMR) in humans

3.5 Infection Prevention and Control (IPC) in human health care

3.6 Optimizing antimicrobial use in human health

3.7 Adoption of “AWaRe” classification of antibiotics in the National Essential Medicines List

3.4.3b Capacity to perform AST for critically important fungi.

3.4.2b Capacity to perform AST for critically important bacteria.

3.4.5b Continuity of services for clinical bacteriology labs - mechanism to report stockouts.

4.1 Training and professional education on AMR in the veterinary sector

4.2 Training and professional education on AMR in the aquatic animal health sector

4.3 Progress with strengthening veterinary services

4.4 Progress with strengthening aquatic animal health services

4.7 National surveillance system for antimicrobial resistance (AMR) in live terrestrial animals

4.8 National surveillance system for antimicrobial resistance (AMR) in live aquatic animals

4.9 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in terrestrial animal production

4.10 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in aquatic animal production

4.11 Optimizing antimicrobial use in terrestrial animal health

4.12 Optimizing antimicrobial use in aquatic animal health

5.1 Training and professional education on AMR provided to the agriculture (animal and plant), food production, food safety and the environment sectors

5.2 National monitoring system for antimicrobial- pesticide use in plant production including bactericides and fungicides

5.4a National AMR Laboratory network in animal health and food safety sectors - Effective integration of laboratories in the AMR surveillance

5.4b National AMR Laboratory network in animal health and food safety sectors - Level of the standardization and harmonization of procedures among laboratories included in the AMR surveillance system

5.4c National AMR Laboratory network in animal health and food safety sectors - Relevance of diagnostic techniques used by laboratories included in the AMR surveillance system

5.4d National AMR Laboratory network in animal health and food safety sectors - Technical level of data management of the laboratory network in the AMR surveillance system

5.5 Good manufacturing and hygiene practices to reduce the development and transmission of AMR in food processing

5.6 Optimizing antimicrobial pesticide such as bactericides and fungicides use in plant production

6.1 Has a national assessment of risks for residues of antimicrobial compounds and antimicrobial resistant pathogens in the environment been conducted?

6.2 Country has legislation and/or regulations to prevent contamination of the environment with antimicrobials- antimicrobial compounds and their metabolites discharged to the environment

6.3 Is there a system for regular monitoring (passive surveillance) of antimicrobial compounds and their metabolites (or residues) and resistant bacteria or antimicrobial resistance genes (ARGs) in water quality